美国慢性肾脏病患者心血管事件超额风险较日本主要由左心室结构和功能介导
比较美国CRIC队列3125例与日本CKD-JAC队列1097例透析前慢性肾脏病患者,美国患者左心室质量指数更高、射血分数更低,随访中位5年心血管疾病风险更高(校正HR 3.66),左心室质量指数、射血分数及其组合分别介导心血管疾病差异的27%、50%和57%。
要点
- 美国透析前慢性肾脏病患者心血管疾病风险显著高于日本患者(校正HR 3.66)。
- 左心室质量指数和射血分数是心血管疾病差异的主要介导因素(分别介导27%和50%)。
- 即使射血分数在正常范围内,较低射血分数和高左心室质量指数仍预测心血管疾病。
核心结论
- 美国透析前慢性肾脏病患者心血管疾病超额风险主要由左心室结构和功能介导,超声心动图参数比实验室指标介导作用更强。
研究设计与样本
- 比较美国慢性肾功能不全队列(CRIC)3125例与日本CKD-JAC队列1097例透析前慢性肾脏病患者。
主要发现
- CRIC与CKD-JAC平均左心室质量指数分别为55.7和46.6 g/m2,射血分数分别为54%和65%(均显著)。
- 体重指数分别为32和24 kg/m2,很大程度上解释了左心室质量指数和C反应蛋白水平的队列差异。
- 中位随访5年,CRIC参与者心血管疾病风险更高(校正HR 3.66,95%CI 2.74-4.89),死亡风险更高(校正HR 4.69,95%CI 3.05-7.19)。
- 左心室质量指数、射血分数及其组合分别介导心血管疾病差异的27%、50%和57%,分别介导充血性心力衰竭差异的33%、62%和70%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While patients receiving dialysis therapy in the United States are more likely to develop cardiovascular disease (CVD) than those in Japan, direct comparisons of patients with predialysis chronic kidney disease (CKD) are rare. To study this, we compared various outcomes in patients with predialysis CKD using data from the Chronic Renal Insufficiency Cohort (CRIC) and CKD Japan Cohort (CKD-JAC) studies and determined mediators of any differences. Candidate mediators included left ventricular (LV) indices assessed by echocardiography. Among 3125 CRIC and 1097 CKD-JAC participants, the mean LV mass index (LVMI) and ejection fraction (EF) were 55.7 and 46.6 g/m2 and 54% and 65%, respectively (both significant). The difference in body mass index (32 and 24 kg/m2, respectively) largely accounted for the differences in LVMI and C-reactive protein levels across cohorts. Low EF and high LVMI were significantly associated with subsequent CVD in both cohorts. During a median follow-up of five years, CRIC participants were at higher risk for CVD (adjusted hazard ratio [95% confidence interval]: 3.66 [2.74-4.89]) and death (4.69 [3.05-7.19]). A three-fold higher C-reactive protein concentration and higher phosphate levels in the United States cohort were moderately strong mediators of the differences in CVD. However, echocardiographic parameters were stronger mediators than these laboratory measures. LVMI, EF and their combination mediated the observed difference in CVD (27%, 50%, and 57%, respectively) and congestive heart failure (33%, 62%, and 70%, respectively). Thus, higher LV mass and lower EF, even in the normal range, were found to be predictive of CVD in CKD.
引用
- Imaizumi T, Fujii N, Hamano T, et al. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function. Kidney Int. 2023. PMID: 36738890. doi:10.1016/j.kint.2023.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。